About Us
Company Introduction
Strategic Development
Social Responsibility
Scientific Research
Innovative Layout
Innovative Field
International
Global Expansion
Cooperative Partner
Global R&D Centers
International Cooperation
Investor Relations
Information Disclosure
Corporate Governance
Stock Information
ESG
Contact us
Products Services
Product center
Product branding
Quality & Safety
News
Company News
Media Coverage
Media Inquiries
Multimedia zone
Career
Talent
R&D Team
Employee Life
Job Opportunities
EN
CN
About Us
· Company Introduction
· Strategic Development
· Social Responsibility
Scientific Research
· Innovative Layout
· Innovative Field
Products Services
· Product center
· Product branding
· Quality & Safety
News
· Company News
· Media Coverage
· Media Inquiries
· Multimedia zone
Vocational
· Concept about Talent
· R&D Team
· Employee Life
· Job Opportunities
>
News
>
Company
Return
2024 Grand Pharma Annual Report
2025-05-06
Prev
Next
Related news
The Phase II Clinical Trial in China of Grand Pharma’s Class 1 Innovative Traditional Chinese Medicine GPN01360 Successfully Reaches the Clinical Endpoint
2025-12-09
The Phase IIa Clinical Study Conducted in China of Grand Pharma’s Global Innovative Ophthalmic Drug GPN00884 Has Completed the First Patient Enrollment
2025-10-26
The Registration Clinical Study Conducted in China of the Global Innovative Temperature-Sensitive Embolic Agent Has Completed All Patients Enrollment
2025-10-09
